203 related articles for article (PubMed ID: 9802851)
1. Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors.
Dickinson LD; Miller LD; Patel CP; Gupta SK
Neurosurgery; 1998 Nov; 43(5):1074-81. PubMed ID: 9802851
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of postdischarge administration of enoxaparin in the prevention of deep venous thrombosis after total hip replacement. A prospective randomised double-blind placebo-controlled trial.
Planes A; Vochelle N; Darmon JY; Fagola M; Bellaud M; Compan D; Saliba E; Weisslinger N; Huet Y
Drugs; 1996; 52 Suppl 7():47-54. PubMed ID: 9042560
[TBL] [Abstract][Full Text] [Related]
3. Low-molecular-weight heparin and unfractionated heparin in prophylaxis against deep vein thrombosis in critically ill patients undergoing major surgery.
De A; Roy P; Garg VK; Pandey NK
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):57-61. PubMed ID: 19844176
[TBL] [Abstract][Full Text] [Related]
4. Comparison of two low-molecular-weight heparins for the prevention of postoperative venous thromboembolism after elective hip surgery. Reviparin Study Group.
Planès A; Vochelle N; Fagola M; Bellaud M
Blood Coagul Fibrinolysis; 1998 Sep; 9(6):499-505. PubMed ID: 9819000
[TBL] [Abstract][Full Text] [Related]
5. The effect of enoxaparin in prevention of deep venous thrombosis in hip and knee surgery--a comparison with the dihydroergotamine-heparin combination.
Perhoniemi V; Vuorinen J; Myllynen P; Kivioja A; Lindevall K
Ann Chir Gynaecol; 1996; 85(4):359-63. PubMed ID: 9014067
[TBL] [Abstract][Full Text] [Related]
6. Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo.
Planes A; Vochelle N; Darmon JY; Fagola M; Bellaud M; Huet Y
Lancet; 1996 Jul; 348(9022):224-8. PubMed ID: 8684199
[TBL] [Abstract][Full Text] [Related]
7. Low molecular weight heparin (enoxaparin) compared with unfractionated heparin in prophylaxis of deep venous thrombosis and pulmonary embolism in patients undergoing hip replacement.
Avikainen V; von Bonsdorff H; Partio E; Kaira P; Hakkinen S; Usenius JP; Kaaja R
Ann Chir Gynaecol; 1995; 84(1):85-90. PubMed ID: 7645915
[TBL] [Abstract][Full Text] [Related]
8. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement.
Bergqvist D; Benoni G; Björgell O; Fredin H; Hedlundh U; Nicolas S; Nilsson P; Nylander G
N Engl J Med; 1996 Sep; 335(10):696-700. PubMed ID: 8703168
[TBL] [Abstract][Full Text] [Related]
9. Incidence of venous thromboembolism and hemorrhage related safety studies of preoperative anticoagulation therapy in hip fracture patients undergoing surgical treatment: a case-control study.
Liu Z; Han N; Xu H; Fu Z; Zhang D; Wang T; Jiang B
BMC Musculoskelet Disord; 2016 Feb; 17():76. PubMed ID: 26873584
[TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy and safety of once-daily enoxaparin plus warfarin for the outpatient ambulatory treatment of lower-limb deep vein thrombosis in the TROMBOTEK trial.
Kurtoglu M; Koksoy C; Hasan E; Akcalı Y; Karabay O; Filizcan U;
J Vasc Surg; 2010 Nov; 52(5):1262-70. PubMed ID: 20732787
[TBL] [Abstract][Full Text] [Related]
11. [General perioperative prevention of thromboembolism in gynecology with low-molecular weight heparin: clinical experiences with enoxaparin over 7 years].
Slunsky R
Zentralbl Gynakol; 1995; 117(11):598-601. PubMed ID: 8533494
[TBL] [Abstract][Full Text] [Related]
12. Low molecular weight heparin (enoxaparin) versus oral anticoagulant therapy (acenocoumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial.
Veiga F; Escribá A; Maluenda MP; López Rubio M; Margalet I; Lezana A; Gallego J; Ribera JM
Thromb Haemost; 2000 Oct; 84(4):559-64. PubMed ID: 11057850
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant enoxaparin therapy may decrease the incidence of postoperative thrombotic events though does not increase the incidence of postoperative intracranial hemorrhage in patients with meningiomas.
Cage TA; Lamborn KR; Ware ML; Frankfurt A; Chakalian L; Berger MS; McDermott MW
J Neurooncol; 2009 May; 93(1):151-6. PubMed ID: 19430892
[TBL] [Abstract][Full Text] [Related]
14. Enoxaparin. A reappraisal of its pharmacology and clinical applications in the prevention and treatment of thromboembolic disease.
Noble S; Peters DH; Goa KL
Drugs; 1995 Mar; 49(3):388-410. PubMed ID: 7774513
[TBL] [Abstract][Full Text] [Related]
15. An open-label, comparative study of the efficacy and safety of once-daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis.
Ramacciotti E; Araújo GR; Lastoria S; Maffei FH; Karaoglan de Moura L; Michaelis W; Sandri JL; Dietrich-Neto F;
Thromb Res; 2004; 114(3):149-53. PubMed ID: 15342210
[TBL] [Abstract][Full Text] [Related]
16. The EFFORT trial: Preoperative enoxaparin versus postoperative fondaparinux for thromboprophylaxis in bariatric surgical patients: a randomized double-blind pilot trial.
Steele KE; Canner J; Prokopowicz G; Verde F; Beselman A; Wyse R; Chen J; Streiff M; Magnuson T; Lidor A; Schweitzer M
Surg Obes Relat Dis; 2015; 11(3):672-83. PubMed ID: 25620436
[TBL] [Abstract][Full Text] [Related]
17. Postoperative deep vein thrombosis prophylaxis: a retrospective analysis in 1000 consecutive hip fracture patients treated in a community hospital setting.
Ennis RS
J South Orthop Assoc; 2003; 12(1):10-7. PubMed ID: 12735619
[TBL] [Abstract][Full Text] [Related]
18. Extended Duration Enoxaparin Decreases the Rate of Venous Thromboembolic Events after Radical Cystectomy Compared to Inpatient Only Subcutaneous Heparin.
Pariser JJ; Pearce SM; Anderson BB; Packiam VT; Prachand VN; Smith ND; Steinberg GD
J Urol; 2017 Feb; 197(2):302-307. PubMed ID: 27569434
[TBL] [Abstract][Full Text] [Related]
19. [Prospective randomized study comparing the effectiveness and tolerance of various low-molecular-weight heparins in high risk patients].
Janni W; Bergauer F; Rjosk D; Lohscheidt K; Hagena FW
Zentralbl Chir; 2001 Jan; 126(1):32-8. PubMed ID: 11227291
[TBL] [Abstract][Full Text] [Related]
20. A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery.
Scholten DJ; Hoedema RM; Scholten SE
Obes Surg; 2002 Feb; 12(1):19-24. PubMed ID: 11868291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
